查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612150

Aminoglycosides市场：副产品、给药途径和应用 - 2025-2030 年全球预测

Aminoglycosides Market by Product (Amikacin, Gentamicin, Kanamycin), Route of Administration (Injectables, Oral, Topical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Aminoglycosides市值为19.3亿美元，预计2024年将达20.2亿美元，复合年增长率为4.76%，预计2030年将达26.7亿美元。

Aminoglycosides是一种抗生素，用于治疗主要由革兰氏阴性菌引起的严重细菌感染疾病。它在医学领域的重要性在于它可以有效治疗败血症和结核病等危及生命的感染疾病，尤其是在其他抗生素无效的情况下。Aminoglycosides药物的应用涵盖人类医学和兽医学，在牲畜保健、确保食品安全和预防疾病爆发方面发挥重要作用。最终用途包括医院、诊所、研究机构和药品製造。Aminoglycosides市场受到抗生素抗药性增加等因素的影响，凸显了对有效治疗的需求，推动了市场需求。此外，新兴国家细菌感染疾病的增加也提供了巨大的成长潜力。然而，市场面临挑战，例如严格的法律规范以及与过度使用相关的潜在毒性（例如肾毒性和耳毒性）。探索潜力，开发减少副作用、提高疗效的Aminoglycosides衍生物还有相当大的创新空间。专注于联合治疗以减少抗药性发展的研发投资可能会进一步推动市场成长。此外，市场相关人员应探索与生技公司合作，开发可提高Aminoglycosides使用精确度的药物输送系统。主要发展包括高昂的开发成本和冗长的核准流程，这对新进入者构成了威慑。然而，政府对抗生素抗药性研究的激励和资助可能会减轻财务负担。个人化医疗的趋势提供了一条市场扩张之路，因为抗生素可以根据个别患者的需求进行客製化，从而有可能优化治疗结果。市场竞争是研究主导的，为优先考虑创新和策略联盟的公司创造了机会。

主要市场统计
基准年[2023] 19.3亿美元
预测年份 [2024] 20.2亿美元
预测年份 [2030] 26.7亿美元
复合年增长率（%） 4.76%

市场动态：揭示快速发展的Aminoglycosides市场的关键市场洞察

供需的动态交互作用正在改变Aminoglycosides市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对革兰氏阴性病菌感染有效治疗的需求不断增加
    • 使用动物用药品治疗动物感染疾病
  • 市场限制因素
    • Aminoglycosides开发与生产的复杂性
  • 市场机会
    • Aminoglycosides药物递送系统的进展
    • Aminoglycosides抗药性机制的研究进展
  • 市场挑战
    • Aminoglycosides的副作用和毒性

波特五力：驾驭Aminoglycosides市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Aminoglycosides市场的外部影响

外部宏观环境因素在塑造Aminoglycosides市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解Aminoglycosides市场的竞争状况

对Aminoglycosides市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵Aminoglycosides市场供应商的绩效评估

FPNV定位矩阵是评估Aminoglycosides市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了Aminoglycosides市场的成功之路

Aminoglycosides市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对革兰氏阴性菌感染疾病的有效治疗方法的需求日益增长
      • 兽药在治疗动物感染疾病的应用
    • 抑制因素
      • Aminoglycosides开发与生产的复杂性
    • 机会
      • Aminoglycosides药物递送系统的进展
      • Aminoglycosides抗药性机制的研究进展
    • 任务
      • Aminoglycosides的副作用和毒性
  • 市场区隔分析
    • 产品：庆大霉素，广泛用于治疗血液、腹部、肺部、皮肤和软组织感染疾病。
    • 应用：Aminoglycosides药物用于治疗整体呼吸系统疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Aminoglycosides市场：副产品

  • Amikacin
  • 庆大霉素
  • 卡那霉素
  • 新霉素
  • Paromomycin
  • 链霉素
  • 妥布霉素

第七章Aminoglycosides市场：依给药途径分类

  • 注射
  • 口服
  • 话题

第八章Aminoglycosides市场：依应用分类

  • 呼吸系统疾病
  • 皮肤感染疾病
  • 尿道感染及骨盆腔疾病
  • 兽医学

第九章美洲Aminoglycosides市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太Aminoglycosides市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲Aminoglycosides市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Cipla Limited 在印度推出用于治疗进行性尿道感染的 plazomicin
    • Aminoglycosides抗生素的创新可提高安全性：降低听力损失的风险
    • BDR Pharmaceuticals 推出尼洛替尼，一种治疗罕见儿童和成人白血病的新方法
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • AstraZeneca plc
  • Bristol Myers Squibb Company
  • Cipla Limited
  • GlaxoSmithKline plc
  • Hangzhou Uniwise International Co., Ltd.
  • HuvePharma
  • Insmed Incorporated
  • Jiangxi Bolai Pharmacy Co., Ltd.
  • Kremoint Pharma Pvt. Ltd
  • Medico Remedies Pvt. Ltd.
  • Medson Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Vega Pharma Ltd.
  • Zoetis Inc.
Product Code: MRR-5D693B46C82A

The Aminoglycosides Market was valued at USD 1.93 billion in 2023, expected to reach USD 2.02 billion in 2024, and is projected to grow at a CAGR of 4.76%, to USD 2.67 billion by 2030.

Aminoglycosides are a class of antibiotics used primarily to treat severe bacterial infections, particularly those caused by gram-negative bacteria. Their importance in the medical field stems from their effectiveness in treating life-threatening infections like sepsis and tuberculosis, especially when other antibiotics fail. The application of aminoglycosides spans human and veterinary medicine, where they play a crucial role in livestock healthcare, ensuring food safety, and the prevention of disease outbreaks. The end-use scope extends to hospitals, clinics, research institutions, and pharmaceutical manufacturing. The market for aminoglycosides is influenced by factors such as rising antibiotic resistance, which underscores the necessity for effective treatments and drives market demand. Additionally, the growing incidences of bacterial infections in emerging economies provide significant growth potential. However, the market faces challenges from stringent regulatory frameworks and the potential for toxicity associated with overuse, such as nephrotoxicity and ototoxicity. Exploring potential opportunities, there is considerable room for innovation in developing aminoglycoside derivatives with reduced side effects and enhanced efficacy. Investment in research focused on combination therapies that reduce resistance development can further propel market growth. Moreover, market players should explore joint ventures with biotechnological firms to advance drug delivery systems that enhance the precision of aminoglycoside usage. Key limitations include the high cost of development and the lengthy approval process, which can deter new entrants. However, government incentives and funding for antibiotic resistance research may alleviate some financial burdens. Trends toward personalized medicine present an avenue for market expansion, as tailoring antibiotics to individual patient needs could optimize therapeutic outcomes. The nature of the aminoglycosides market is competitive and research-driven, presenting opportunities for enterprises that prioritize innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 1.93 billion
Estimated Year [2024] USD 2.02 billion
Forecast Year [2030] USD 2.67 billion
CAGR (%) 4.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aminoglycosides Market

The Aminoglycosides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in need for effective treatments for gram-negative bacterial infections
    • Utilization veterinary medicine to treat infections in animals
  • Market Restraints
    • Complexities in development and manufacturing of aminoglycosides
  • Market Opportunities
    • Advancements in drug delivery systems for aminoglycosides
    • Research and development into aminoglycoside resistance mechanisms
  • Market Challenges
    • Side effects and toxicity caused due to aminoglycosides

Porter's Five Forces: A Strategic Tool for Navigating the Aminoglycosides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aminoglycosides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aminoglycosides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aminoglycosides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aminoglycosides Market

A detailed market share analysis in the Aminoglycosides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aminoglycosides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aminoglycosides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aminoglycosides Market

A strategic analysis of the Aminoglycosides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aminoglycosides Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bristol Myers Squibb Company, Cipla Limited, GlaxoSmithKline plc, Hangzhou Uniwise International Co., Ltd., HuvePharma, Insmed Incorporated, Jiangxi Bolai Pharmacy Co., Ltd., Kremoint Pharma Pvt. Ltd, Medico Remedies Pvt. Ltd., Medson Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Vega Pharma Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aminoglycosides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Amikacin, Gentamicin, Kanamycin, Neomycin, Paromomycin, Streptomycin, and Tobramycin.
  • Based on Route of Administration, market is studied across Injectables, Oral, and Topical.
  • Based on Application, market is studied across Respiratory Diseases, Skin Infection, UTI & Pelvic Diseases, and Veterinary Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in need for effective treatments for gram-negative bacterial infections
      • 5.1.1.2. Utilization veterinary medicine to treat infections in animals
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in development and manufacturing of aminoglycosides
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in drug delivery systems for aminoglycosides
      • 5.1.3.2. Research and development into aminoglycoside resistance mechanisms
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and toxicity caused due to aminoglycosides
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide utilization of gentamicin to treat infections in the blood, abdomen, lungs, skin, and soft tissues
    • 5.2.2. Application: Employment of aminoglycosides across respiratory diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aminoglycosides Market, by Product

  • 6.1. Introduction
  • 6.2. Amikacin
  • 6.3. Gentamicin
  • 6.4. Kanamycin
  • 6.5. Neomycin
  • 6.6. Paromomycin
  • 6.7. Streptomycin
  • 6.8. Tobramycin

7. Aminoglycosides Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectables
  • 7.3. Oral
  • 7.4. Topical

8. Aminoglycosides Market, by Application

  • 8.1. Introduction
  • 8.2. Respiratory Diseases
  • 8.3. Skin Infection
  • 8.4. UTI & Pelvic Diseases
  • 8.5. Veterinary Medicine

9. Americas Aminoglycosides Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aminoglycosides Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aminoglycosides Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Cipla Limited Unveils Plazomicin for Advanced Urinary Tract Infection Management in India
    • 12.3.2. Innovating Aminoglycoside Antibiotics for Enhanced Safety: Mitigating Hearing Loss Risks
    • 12.3.3. BDR Pharmaceuticals Launches Nilotinib: A Novel Approach in the Treatment of Rare Childhood and Adult Leukemia
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AstraZeneca plc
  • 3. Bristol Myers Squibb Company
  • 4. Cipla Limited
  • 5. GlaxoSmithKline plc
  • 6. Hangzhou Uniwise International Co., Ltd.
  • 7. HuvePharma
  • 8. Insmed Incorporated
  • 9. Jiangxi Bolai Pharmacy Co., Ltd.
  • 10. Kremoint Pharma Pvt. Ltd
  • 11. Medico Remedies Pvt. Ltd.
  • 12. Medson Pharmaceuticals
  • 13. Novartis AG
  • 14. Pfizer Inc.
  • 15. Teva Pharmaceutical Industries Ltd
  • 16. Vega Pharma Ltd.
  • 17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. AMINOGLYCOSIDES MARKET RESEARCH PROCESS
  • FIGURE 2. AMINOGLYCOSIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AMINOGLYCOSIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AMINOGLYCOSIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PAROMOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY UTI & PELVIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023